Loading clinical trials...
Loading clinical trials...
Randomized,Open Label,Balanced,Two Treatment, Four Period, Two Sequence, Single Oral Dose, Crossover, Replicate Study Under Fasting Conditions to Test Within Subject Variability of 20mg ER Torsemide and Demadex Tablets in Healthy Adults
Conditions
Interventions
Demadex 20mg Tablet
ER Torsemide 20mg Tablet
Locations
1
India
I.E.C. Consultants
Bangalore, India
Start Date
June 19, 2017
Primary Completion Date
July 20, 2017
Completion Date
July 20, 2017
Last Updated
April 18, 2018
NCT04592640
NCT07094906
NCT05507879
NCT04551560
NCT07358572
NCT05099770
Lead Sponsor
Sarfez Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions